X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse Cadila Healthcare with ACTAVIS INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CADILA HEALTHCARE vs ACTAVIS (US) - Comparison Results

CADILA HEALTHCARE    Change

Cadila Healthcare is one of the leading players in the Indian pharma market having a presence in both the domestic and international markets. In the international markets, the company had adopted the strategy of competing directly in the generics mar... More

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 CADILA HEALTHCARE   ACTAVIS
EQUITY SHARE DATA
    CADILA HEALTHCARE
Mar-18
ACTAVIS
Dec-14
CADILA HEALTHCARE/
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs55818,853-   
Low Rs36211,500-   
Sales per share (Unadj.) Rs116.33,394.9-  
Earnings per share (Unadj.) Rs17.9-423.7-  
Cash flow per share (Unadj.) Rs23.1311.5-  
Dividends per share (Unadj.) Rs3.500-  
Dividend yield (eoy) %0.80-  
Book value per share (Unadj.) Rs85.47,363.5-  
Shares outstanding (eoy) m1,023.74265.90-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.04.5 88.4%   
Avg P/E ratio x25.7-35.8 -71.8%  
P/CF ratio (eoy) x19.948.7 40.8%  
Price / Book Value ratio x5.42.1 261.1%  
Dividend payout %19.60-   
Avg Mkt Cap Rs m470,6644,035,446 11.7%   
No. of employees `00011.821.6 54.7%   
Total wages/salary Rs m18,5450-   
Avg. sales/employee Rs Th10,072.741,792.4 24.1%   
Avg. wages/employee Rs Th1,569.10-   
Avg. net profit/employee Rs Th1,547.7-5,215.2 -29.7%   
INCOME DATA
Net Sales Rs m119,049902,715 13.2%  
Other income Rs m1,132-2,253 -50.2%   
Total revenues Rs m120,181900,462 13.3%   
Gross profit Rs m28,475115,967 24.6%  
Depreciation Rs m5,388195,471 2.8%   
Interest Rs m91128,473 3.2%   
Profit before tax Rs m23,308-110,230 -21.1%   
Minority Interest Rs m6280-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-8,086 0.0%   
Tax Rs m5,644-5,667 -99.6%   
Profit after tax Rs m18,292-112,649 -16.2%  
Gross profit margin %23.912.8 186.2%  
Effective tax rate %24.25.1 471.0%   
Net profit margin %15.4-12.5 -123.1%  
BALANCE SHEET DATA
Current assets Rs m82,005475,615 17.2%   
Current liabilities Rs m60,720346,863 17.5%   
Net working cap to sales %17.914.3 125.4%  
Current ratio x1.41.4 98.5%  
Inventory Days Days7358 126.1%  
Debtors Days Days9866 148.3%  
Net fixed assets Rs m83,703110,230 75.9%   
Share capital Rs m1,0240-   
"Free" reserves Rs m86,4210-   
Net worth Rs m87,4451,957,955 4.5%   
Long term debt Rs m25,5511,026,007 2.5%   
Total assets Rs m180,6533,588,288 5.0%  
Interest coverage x26.6-2.9 -925.9%   
Debt to equity ratio x0.30.5 55.8%  
Sales to assets ratio x0.70.3 261.9%   
Return on assets %10.6-2.3 -453.1%  
Return on equity %20.9-5.8 -363.6%  
Return on capital %22.0-3.0 -730.3%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m31,4410-   
CASH FLOW
From Operations Rs m9,193155,014 5.9%  
From Investments Rs m-9,737-371,162 2.6%  
From Financial Activity Rs m515208,539 0.2%  
Net Cashflow Rs m-29-7,609 0.4%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 69.11 Rs / USD

Compare CADILA HEALTHCARE With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare CADILA HEALTHCARE With: JUBILANT LIFE SCIENCES  MERCK  AUROBINDO PHARMA  SANOFI INDIA  ORCHID PHARMA LTD  



Today's Market

Sensex Ends Marginally Higher; Realty and IT Stocks Witness Buying(Closing)

Indian share markets witnessed volatility during closing hours and ended their day marginally higher. Gains were largely seen in the realty sector and IT sector.

Related Views On News

CADILA HEALTHCARE Announces Quarterly Results (3QFY19); Net Profit Down 3.7% (Quarterly Result Update)

Feb 12, 2019 | Updated on Feb 12, 2019

For the quarter ended December 2018, CADILA HEALTHCARE has posted a net profit of Rs 5 bn (down 3.7% YoY). Sales on the other hand came in at Rs 36 bn (up 9.8% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

CADILA HEALTHCARE Announces Quarterly Results (2QFY19); Net Profit Down 18.6% (Quarterly Result Update)

Nov 5, 2018 | Updated on Nov 5, 2018

For the quarter ended September 2018, CADILA HEALTHCARE has posted a net profit of Rs 4 bn (down 18.6% YoY). Sales on the other hand came in at Rs 30 bn (down 8.4% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

CADILA HEALTHCARE 2017-18 Annual Report Analysis (Annual Result Update)

Aug 16, 2018 | Updated on Aug 16, 2018

Here's an analysis of the annual report of CADILA HEALTHCARE for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of CADILA HEALTHCARE. Also includes updates on the valuation of CADILA HEALTHCARE.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

Are You Ready for the Big Nifty Move in the March Expiry?(Profit Hunter)

Mar 8, 2019

History suggests the Nifty could make a big move in March. Are you prepared to benefit from this opportunity?

Smallcaps Are Rallying and You Need to Make the Most of It Now(Profit Hunter)

Mar 7, 2019

Did you just miss the smallcap rally? Or is there still time to catch up? Read on for answers and more...

The One Sector to Bet on Today as India Grows into a 10 Trillion Dollar Economy(The 5 Minute Wrapup)

Mar 7, 2019

India's defence sector is suddenly under the spotlight. Can this sector ride along India's long-term growth story?

Elections Don't Matter!(The Honest Truth)

Mar 13, 2019

Ajit Dayal shows us why from the point of view of the Indian economy, elections don't matter.

Two Growth Stocks that Doubled in a Little Over 12 Months!(The 5 Minute Wrapup)

Mar 13, 2019

The elements that fueled profit growth for these two companies led to a surge in their stock prices.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

CADILA HEALTHCARE SHARE PRICE


Mar 20, 2019 (Close)

TRACK CADILA HEALTHCARE

  • Track your investment in CADILA HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON CADILA HEALTHCARE

CADILA HEALTHCARE - SUN PHARMA COMPARISON

COMPARE CADILA HEALTHCARE WITH

MARKET STATS